207 related articles for article (PubMed ID: 21282608)
1. Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.
Lin WH; Griffin DE; Rota PA; Papania M; Cape SP; Bennett D; Quinn B; Sievers RE; Shermer C; Powell K; Adams RJ; Godin S; Winston S
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2987-92. PubMed ID: 21282608
[TBL] [Abstract][Full Text] [Related]
2. Measles vaccination of macaques by dry powder inhalation.
de Swart RL; LiCalsi C; Quirk AV; van Amerongen G; Nodelman V; Alcock R; Yüksel S; Ward GH; Hardy JG; Vos H; Witham CL; Grainger CI; Kuiken T; Greenspan BJ; Gard TG; Osterhaus AD
Vaccine; 2007 Jan; 25(7):1183-90. PubMed ID: 17084489
[TBL] [Abstract][Full Text] [Related]
3. Current progress in pulmonary delivery of measles vaccine.
Griffin DE
Expert Rev Vaccines; 2014 Jun; 13(6):751-9. PubMed ID: 24837839
[TBL] [Abstract][Full Text] [Related]
4. Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA.
Lin WH; Pan CH; Adams RJ; Laube BL; Griffin DE
mBio; 2014 Apr; 5(2):e01047. PubMed ID: 24736226
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of dry powder measles vaccine administered by inhalation: a randomized controlled Phase I clinical trial.
; Cape S; Chaudhari A; Vaidya V; Mulay R; Agarkhedkar S; Shermer C; Collins M; Anderson R; Agarkhedkar S; Kulkarni PS; Winston S; Sievers R; Dhere RM; Gunale B; Powell K; Rota PA; Papania M
Vaccine; 2014 Nov; 32(50):6791-7. PubMed ID: 25446830
[TBL] [Abstract][Full Text] [Related]
6. Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.
Pasetti MF; Resendiz-Albor A; Ramirez K; Stout R; Papania M; Adams RJ; Polack FP; Ward BJ; Burt D; Chabot S; Ulmer J; Barry EM; Levine MM
Clin Pharmacol Ther; 2007 Dec; 82(6):672-85. PubMed ID: 17971812
[TBL] [Abstract][Full Text] [Related]
7. Measles Vaccine.
Griffin DE
Viral Immunol; 2018 Mar; 31(2):86-95. PubMed ID: 29256824
[TBL] [Abstract][Full Text] [Related]
8. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.
Polack FP; Lydy SL; Lee SH; Rota PA; Bellini WJ; Adams RJ; Robinson HL; Griffin DE
Clin Vaccine Immunol; 2013 Feb; 20(2):205-10. PubMed ID: 23239799
[TBL] [Abstract][Full Text] [Related]
9. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles.
Polack FP; Lee SH; Permar S; Manyara E; Nousari HG; Jeng Y; Mustafa F; Valsamakis A; Adams RJ; Robinson HL; Griffin DE
Nat Med; 2000 Jul; 6(7):776-81. PubMed ID: 10888926
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.
Pan CH; Nair N; Adams RJ; Zink MC; Lee EY; Polack FP; Singh M; O'Hagan DT; Griffin DE
Clin Vaccine Immunol; 2008 Apr; 15(4):697-706. PubMed ID: 18287579
[TBL] [Abstract][Full Text] [Related]
11. A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.
Joyce JC; Carroll TD; Collins ML; Chen MH; Fritts L; Dutra JC; Rourke TL; Goodson JL; McChesney MB; Prausnitz MR; Rota PA
J Infect Dis; 2018 Jun; 218(1):124-132. PubMed ID: 29701813
[TBL] [Abstract][Full Text] [Related]
12. A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
Simon JK; Pasetti MF; Viret JF; Mischler R; Muñoz A; Lagos R; Levine MM; Campbell JD
Hum Vaccin; 2007; 3(2):54-8. PubMed ID: 17312403
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.
Yee JL; ; McChesney MB; Christe KL
Comp Med; 2015 Oct; 65(5):448-54. PubMed ID: 26473350
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
[TBL] [Abstract][Full Text] [Related]
15. Dry powder measles vaccine: particle deposition, virus replication, and immune response in cotton rats following inhalation.
Kisich KO; Higgins MP; Park I; Cape SP; Lindsay L; Bennett DJ; Winston S; Searles J; Sievers RE
Vaccine; 2011 Jan; 29(5):905-12. PubMed ID: 20974303
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of a canine distemper-measles and a standard measles vaccine for immunization of rhesus macaques (Macaca mulatta).
Christe KL; McChesney MB; Spinner A; Rosenthal AN; Allen PC; Valverde CR; Roberts JA; Lerche NW
Comp Med; 2002 Oct; 52(5):467-72. PubMed ID: 12405642
[TBL] [Abstract][Full Text] [Related]
17. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
[TBL] [Abstract][Full Text] [Related]
18. Measles: old vaccines, new vaccines.
Griffin DE; Pan CH
Curr Top Microbiol Immunol; 2009; 330():191-212. PubMed ID: 19203111
[TBL] [Abstract][Full Text] [Related]
19. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures.
Lancet; 1977 Sep; 2(8038):571-5. PubMed ID: 71396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
